Nadège Pelletier
Technik-/Wissenschafts-/F&E-Leiter bei BARINTHUS BIOTHERAPEUTICS PLC
Vermögen: - $ am 31.05.2024
Aktive Positionen von Nadège Pelletier
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
BARINTHUS BIOTHERAPEUTICS PLC | Technik-/Wissenschafts-/F&E-Leiter | 01.02.2023 | - |
Karriereverlauf von Nadège Pelletier
Ehemalige bekannte Positionen von Nadège Pelletier
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - | - |
Ausbildung von Nadège Pelletier
Université Claude Bernard Lyon 1 | Doctorate Degree |
École Normale Supérieure de Lyon | Graduate Degree |
Statistik
International
Frankreich | 3 |
Vereinigtes Königreich | 2 |
Vereinigte Staaten | 2 |
Operativ
Chief Tech/Sci/R&D Officer | 1 |
Doctorate Degree | 1 |
Graduate Degree | 1 |
Sektoral
Consumer Services | 3 |
Health Technology | 2 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
BARINTHUS BIOTHERAPEUTICS PLC | Health Technology |
Private Unternehmen | 1 |
---|---|
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Commercial Services |
- Börse
- Insiders
- Nadège Pelletier
- Erfahrung